March 13, 2017 / 10:53 AM / 8 months ago

BRIEF-Aralez Pharmaceuticals reports Q4 loss per share $0.48

March 13 (Reuters) - Aralez Pharmaceuticals Inc

* Aralez reports fourth quarter and full-year 2016 financial results

* Qtrly net revenues increased to $20 million versus $6 million in comparable period of 2015

* Sees 2017 net revenues to be in a range of $80 million to $100 million

* Aralez Pharmaceuticals Inc qtrly loss per share $0.48

* Sees 2017 adjusted EBITDA to be in a range of a loss of $25 million to a loss of $10 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below